FormDSignal
55

Iambic Therapeutics, Inc. raises $66M under Reg D

Company raise · Raising · SAN DIEGO, CA · Form D filed 2026-09-09
$50M+ raise

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Pete OlsonExecutive Officer
Shalini SharpDirector
Fred ManbyExecutive Officer, Director
Evan RachlinDirector
Michael SecoraExecutive Officer
William RastetterDirector
Neil JosephsonExecutive Officer
Thomas MillerExecutive Officer, Director
Jishnu BhattacharjeeDirector
Mary TagliaferriDirector
Kurt von EmsterDirector
R. Jacob VogelsteinDirector
Samit HirawatDirector

Signed by Sunny Chang, General Counsel.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer